Immune response of hepatitis B immunization in pediatric cancer survivors
Completed
- Conditions
- The study is an observational study and aims to evaluate the immune response to hepatitis B immunization in pediatric cancer survivors at Phramongkutklao hospitalhepatitis b virus, immune response, immunization, pediatric, cancer
- Registration Number
- TCTR20201021003
- Lead Sponsor
- Phramongkutklao College of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 107
Inclusion Criteria
The inclusion criteria include patients less than 18 years of age who were diagnosed with cancer at Phramongkutklao hospital and completed chemotherapy for at least 6 months
Exclusion Criteria
Patients who had underlying primary immunodeficiency or on immunosuppressive drugs
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Immune response to hepatitis B immunization 2 years Anti-HBs, Anti-HBc and HBsAg using mean with standard deviation for continuous variables
- Secondary Outcome Measures
Name Time Method Correlation of immune response to hepatitis B immunization and chemotherapy regimens 2 years Independent T-test